302 related articles for article (PubMed ID: 18327152)
1. Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women.
Gass ML; Kagan R; Kohles JD; Martens MG
Menopause; 2008; 15(4 Pt 1):667-75. PubMed ID: 18327152
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
3. Changes in bone resorption during the menstrual cycle.
Chiu KM; Ju J; Mayes D; Bacchetti P; Weitz S; Arnaud CD
J Bone Miner Res; 1999 Apr; 14(4):609-15. PubMed ID: 10234583
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
Schou AJ; Heuck C; Wolthers OD
Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
[TBL] [Abstract][Full Text] [Related]
7. Determinants of bone turnover markers in healthy premenopausal women.
Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
[TBL] [Abstract][Full Text] [Related]
8. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
[TBL] [Abstract][Full Text] [Related]
9. Bone marker alterations in patients with type 1 Gaucher disease.
Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
[TBL] [Abstract][Full Text] [Related]
10. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Withold W
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assessment of Paget's disease of bone.
Shankar S; Hosking DJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
Garnero P; Schott AM; Prockop D; Chevrel G
Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
[TBL] [Abstract][Full Text] [Related]
14. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
15. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
[TBL] [Abstract][Full Text] [Related]
16. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
17. Possible variation in bone resorption during the normal menstrual cycle.
Schlemmer A; Hassager C; Risteli J; Risteli L; Jensen SB; Christiansen C
Acta Endocrinol (Copenh); 1993 Nov; 129(5):388-92. PubMed ID: 8279219
[TBL] [Abstract][Full Text] [Related]
18. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Vescovi JD; VanHeest JL; De Souza MJ
Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
[TBL] [Abstract][Full Text] [Related]
19. Levels of biochemical bone marker procollagen type I N-propeptide (PINP) in Thai women aged 40-70 years.
Boonyanurak P; Wilawan K
J Med Assoc Thai; 2009 Jul; 92(7):873-7. PubMed ID: 19626803
[TBL] [Abstract][Full Text] [Related]
20. [Bone metabolism markers in patients with Basedow-Graves disease].
Vámos A; Balázs C
Orv Hetil; 1997 Sep; 138(38):2403-5. PubMed ID: 9380378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
